Acupuncture for patients with migraine: a randomized controlled trial - PubMed (original) (raw)
Clinical Trial
. 2005 May 4;293(17):2118-25.
doi: 10.1001/jama.293.17.2118.
Andrea Streng, Susanne Jürgens, Andrea Hoppe, Benno Brinkhaus, Claudia Witt, Stephan Wagenpfeil, Volker Pfaffenrath, Michael G Hammes, Wolfgang Weidenhammer, Stefan N Willich, Dieter Melchart
Affiliations
- PMID: 15870415
- DOI: 10.1001/jama.293.17.2118
Free article
Clinical Trial
Acupuncture for patients with migraine: a randomized controlled trial
Klaus Linde et al. JAMA. 2005.
Free article
Abstract
Context: Acupuncture is widely used to prevent migraine attacks, but the available evidence of its benefit is scarce.
Objective: To investigate the effectiveness of acupuncture compared with sham acupuncture and with no acupuncture in patients with migraine.
Design, setting, and patients: Three-group, randomized, controlled trial (April 2002-January 2003) involving 302 patients (88% women), mean (SD) age of 43 (11) years, with migraine headaches, based on International Headache Society criteria. Patients were treated at 18 outpatient centers in Germany.
Interventions: Acupuncture, sham acupuncture, or waiting list control. Acupuncture and sham acupuncture were administered by specialized physicians and consisted of 12 sessions per patient over 8 weeks. Patients completed headache diaries from 4 weeks before to 12 weeks after randomization and from week 21 to 24 after randomization.
Main outcome measures: Difference in headache days of moderate or severe intensity between the 4 weeks before and weeks 9 to 12 after randomization.
Results: Between baseline and weeks 9 to 12, the mean (SD) number of days with headache of moderate or severe intensity decreased by 2.2 (2.7) days from a baseline of 5.2 (2.5) days in the acupuncture group compared with a decrease to 2.2 (2.7) days from a baseline of 5.0 (2.4) days in the sham acupuncture group, and by 0.8 (2.0) days from a baseline if 5.4 (3.0) days in the waiting list group. No difference was detected between the acupuncture and the sham acupuncture groups (0.0 days, 95% confidence interval, -0.7 to 0.7 days; P = .96) while there was a difference between the acupuncture group compared with the waiting list group (1.4 days; 95% confidence interval; 0.8-2.1 days; P<.001). The proportion of responders (reduction in headache days by at least 50%) was 51% in the acupuncture group, 53% in the sham acupuncture group, and 15% in the waiting list group.
Conclusion: Acupuncture was no more effective than sham acupuncture in reducing migraine headaches although both interventions were more effective than a waiting list control.
Comment in
Similar articles
- The Long-term Effect of Acupuncture for Migraine Prophylaxis: A Randomized Clinical Trial.
Zhao L, Chen J, Li Y, Sun X, Chang X, Zheng H, Gong B, Huang Y, Yang M, Wu X, Li X, Liang F. Zhao L, et al. JAMA Intern Med. 2017 Apr 1;177(4):508-515. doi: 10.1001/jamainternmed.2016.9378. JAMA Intern Med. 2017. PMID: 28241154 Clinical Trial. - Acupuncture Randomized Trials (ART) in patients with migraine or tension-type headache--design and protocols.
Melchart D, Linde K, Streng A, Reitmayr S, Hoppe A, Brinkhaus B, Becker-Witt C, Wagenpfeil S, Pfaffenrath V, Hammes M, Willich SN, Weidenhammer W. Melchart D, et al. Forsch Komplementarmed Klass Naturheilkd. 2003 Aug;10(4):179-84. doi: 10.1159/000073473. Forsch Komplementarmed Klass Naturheilkd. 2003. PMID: 12972722 Clinical Trial. - Acupuncture in patients with tension-type headache: randomised controlled trial.
Melchart D, Streng A, Hoppe A, Brinkhaus B, Witt C, Wagenpfeil S, Pfaffenrath V, Hammes M, Hummelsberger J, Irnich D, Weidenhammer W, Willich SN, Linde K. Melchart D, et al. BMJ. 2005 Aug 13;331(7513):376-82. doi: 10.1136/bmj.38512.405440.8F. Epub 2005 Jul 29. BMJ. 2005. PMID: 16055451 Free PMC article. Clinical Trial. - Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis.
Meissner K, Fässler M, Rücker G, Kleijnen J, Hróbjartsson A, Schneider A, Antes G, Linde K. Meissner K, et al. JAMA Intern Med. 2013 Nov 25;173(21):1941-51. doi: 10.1001/jamainternmed.2013.10391. JAMA Intern Med. 2013. PMID: 24126676 Review. - Reporting of clinical details in randomized controlled trials of acupuncture for the treatment of migraine/headaches and nausea/vomiting.
Elorriaga Claraco A, Hanna SE, Fargas-Babjak A. Elorriaga Claraco A, et al. J Altern Complement Med. 2003 Feb;9(1):151-9. doi: 10.1089/107555303321223026. J Altern Complement Med. 2003. PMID: 12676043 Review.
Cited by
- Modulation effects of imagery acupuncture and no-touch double-blinded placebo acupuncture, a cross-over pilot study.
Takakura N, Sacca V, Takayama M, Kong Q, Tanaka T, Yamada T, Imanishi K, Ursitti AK, Zhu M, Yajima H, Kong J. Takakura N, et al. Brain Behav Immun Integr. 2024 Jul;7:100068. doi: 10.1016/j.bbii.2024.100068. Epub 2024 Jul 6. Brain Behav Immun Integr. 2024. PMID: 39309545 Free PMC article. - Enhancing chronic migraine preventive therapy: low-level 810 nm laser acupuncture as an add-on treatment for patients with unsatisfactory pharmacological effect, a pilot single-blind randomized controlled trial.
Wu HY, Wang CS, Liu YC, Chung CC, Chen WL, Tsai CI, Hsu CY, Chou CH. Wu HY, et al. BMC Complement Med Ther. 2024 Aug 28;24(1):318. doi: 10.1186/s12906-024-04617-9. BMC Complement Med Ther. 2024. PMID: 39198866 Free PMC article. Clinical Trial. - The use of acupuncture for addressing neurological and neuropsychiatric symptoms in patients with long COVID: a systematic review and meta-analysis.
Lam WC, Wei D, Li H, Yao L, Zhang S, Lai MXY, Zheng Y, Yeung JWF, Lau AYL, Lyu A, Bian Z, Cheung AM, Zhong LLD. Lam WC, et al. Front Neurol. 2024 Jul 19;15:1406475. doi: 10.3389/fneur.2024.1406475. eCollection 2024. Front Neurol. 2024. PMID: 39099786 Free PMC article. - Research hotspots and trends on acupuncture treatment for headache: a bibliometric analysis from 2003 to 2023.
Zhao S, Hu S, Luo Y, Li W, Zhao F, Wang C, Meng F, He X. Zhao S, et al. Front Neurosci. 2024 Mar 21;18:1338323. doi: 10.3389/fnins.2024.1338323. eCollection 2024. Front Neurosci. 2024. PMID: 38591064 Free PMC article. - Effect of different non-pharmacologic placebo treatments on migraine prevention: a network meta-analysis of randomized controlled trials.
Huang YB, Yuan L, Xiao XY, Wang XY, Feng SJ, Zheng H. Huang YB, et al. Acta Neurol Belg. 2024 Aug;124(4):1125-1139. doi: 10.1007/s13760-023-02460-2. Epub 2024 Jan 21. Acta Neurol Belg. 2024. PMID: 38245660 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous